Discover Top Posts Tagged with #destiny pharma

Popular Recent

Dale Gerding, MD, FACP, FIDSA, FSHEA To Chair the July 16, 2021 C. diff. Patient, Family, and Caregiver Live-Online Symposium

Scientific Advisor Prof Dale Gerding to chair C. diff. Foundation C. diff. Patient, Family, and Caregiver Symposium July 16th – Live-Online beginning at 1:00 p.m. – 3:00 p.m. EDT Register Today! Brighton, United Kingdom – 02 July 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines to prevent…

View On WordPress

#C diff patient information #C. difficile Symposium #CDI and recurrence #Dale Gerding MD #Destiny Pharma #Is there a meeting for Patients with C. diff.?#NTCD-M3 #What is a clinical trial?#What is the Microbiome?#What&039;s a Cdiff recurrence?

Destiny Pharma Update On the Acquired NTCD-M3 Biotherapeutic Clinical Program For Prevention of Recurrence of C. diff. Infections (rCDI)

Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections Press release by Destiny Pharma: Brighton, United Kingdom – 22 December 2020: Destiny Pharma plc (AIM: DEST) a clinical-stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, announces it is…

View On WordPress

#Are there clinical trials for recurrent C. difficile infections?#Dale Gerding MD #Destiny Pharma #non-toxigenic C. difficile strain M3 #NTCD-M3 #Phase 3 rCDI clinical trial #Recurrent CDI prevention

#destiny pharma

Trending Tags

Recently Viewed Tags

#destiny pharma